logo.png
Kanzhun Limited (Nasdaq: BZ) Rings The Nasdaq Stock Market Opening Bell
June 17, 2024 10:40 ET | Kanzhun Limited
BEIJING, June 17, 2024 (GLOBE NEWSWIRE) -- Kanzhun Limited (Nasdaq: BZ), which operates China’s largest online recruitment platform BOSS Zhipin*, visits the Nasdaq MarketSite in Times Square. ...
WTW.jpg
WTW announces appointment of Len Graziano as Casualty Strategy and Execution Leader for CRB NA
June 17, 2024 10:12 ET | Willis Towers Watson US LLC
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of Len Graziano as Casualty Strategy and...
The PGA TOUR Logo
AVIS extends PGA TOUR marketing partnership, adds Xander Schauffele as ambassador
June 17, 2024 10:00 ET | Avis Budget Group, Inc.
PONTE VEDRA BEACH, Fla. and PARSIPPANY, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- AVIS, one of the world’s best known car rental brands, has today announced a multi-year extension of its partnership...
pr-IZZY-1920
IZEA Unveils IZZY: Revolutionary AI Assistant for Influencer Marketing
June 17, 2024 10:00 ET | IZEA Worldwide, Inc.
Cannes, France, June 17, 2024 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of technology, data, and services for the Creator Economy, today announced the launch of...
immix-logoNEW_gray.png
Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum
June 17, 2024 09:35 ET | Immix Biopharma, Inc.
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in...
pineapple-energy-logo.jpg
Pineapple Interim CEO Adds Shares to His Position
June 17, 2024 09:15 ET | Pineapple Energy
Purchase by Pineapple Energy’s Interim CEO Affirms Commitment to Company’s Goals for Growth
SELLAS Logo.png
SELLAS Life Sciences Announces Positive Recommendation from the Independent Data Monitoring Committee of the Phase 3 REGAL Trial in Acute Myeloid Leukemia
June 17, 2024 09:05 ET | SELLAS Life Sciences Group, Inc.
–  The Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Without Any Modifications – –  No Safety or Futility Concerns Were Raised Based on the Efficacy...
iTeos Logo 2022.png
iTeos und GSK starten Phase-III-Studie GALAXIES Lung-301 zur Untersuchung von Belrestotug und Dostarlimab bei zuvor unbehandeltem, inoperablem, lokal fortgeschrittenem/metastasiertem, PD-L1-selektiertem, nicht-kleinzelligem Lungenkrebs
June 17, 2024 09:00 ET | iTeos Therapeutics Inc.
WATERTOWN, Massachusetts, und GOSSELIES, Belgien, June 17, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) („iTeos“), ein im klinischen Stadium tätiges Biopharmazie-Unternehmen, das...
iTeos Logo 2022.png
Début de l’étude GALAXIES Lung-301 de Phase III à l’initiative conjointe d’iTeos et de GSK, visant à évaluer le doublet belrestotug + dostarlimab chez les patients atteints d’un cancer du poumon non à petites cellules PD-L1-positif, localement avancé ou métastatique, non résécable, non préalablement traité
June 17, 2024 09:00 ET | iTeos Therapeutics Inc.
WATERTOWN, État du Massachusetts et GOSSELIES, Belgique, 17 juin 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS), ci-après « iTeos », une société biopharmaceutique au stade...
Longeveron Logo.jpg
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
June 17, 2024 09:00 ET | Longeveron
Longeveron, a clinical stage biotechnology company developing cellular therapies, will present at the Virtual LIfe Sciences Investor Forum on June 20th.